Mindpeak, a Hamburg-based AI pathology startup, raised $15.3M in Series A funding.

ZEISS Ventures and InnoVentureFund led the round, with participation from AI.FUND and the European Innovation Council Fund.

The capital will enhance Mindpeak's AI-driven histopathological solutions for clinical labs and biopharma companies.

Mindpeak, headed by CEO Felix Faber, focuses on automated tissue analysis, improving diagnostic speed and accuracy, especially in cancer care.